By Marisa Wong
Los Angeles, Feb. 25 – JPMorgan Chase Financial Co. LLC priced $1.83 million of 0% uncapped barrier notes due Jan. 21, 2026 linked to the lesser performing of the ARK Innovation exchange-traded fund and the ARK Genomic Revolution ETF, according to a 424B2 filing with the Securities and Exchange Commission.
The notes are guaranteed by JPMorgan Chase & Co.
If each ETF finishes above its initial level, the payout at maturity will be par plus 1.05 times the return of the worse performing ETF.
If either ETF falls but each ETF finishes at or above the 60% barrier level, the payout will be par.
Otherwise, investors will be fully exposed to the decline of the worse performing ETF.
J.P. Morgan Securities LLC is the agent.
| Issuer: | JPMorgan Chase Financial Co. LLC
|
| Guarantor: | JPMorgan Chase & Co.
|
| Issue: | Uncapped barrier notes
|
| Underlying ETFs: | ARK Innovation ETF and ARK Genomic Revolution ETF
|
| Amount: | $1.83 million
|
| Maturity: | Jan. 21, 2026
|
| Coupon: | 0%
|
| Price: | Par
|
| Payout at maturity: | Par plus 1.05 times any gain in worse performing ETF; if either ETF falls but each ETF finishes at or above barrier value, par; otherwise, full exposure to the decline of the worse performing ETF
|
| Initial values: | $141.91 for ARK Innovation and $107.96 for ARK Genomic
|
| Barrier values: | $85.146 for ARK Innovation and $64.776 for ARK Genomic; 60% of initial values
|
| Pricing date: | Jan. 15
|
| Settlement date: | Jan. 21
|
| Agent: | J.P. Morgan Securities LLC
|
| Fees: | 0.67445%
|
| Cusip: | 48132RHP8
|
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.
